ArticleCNS neuroscience & therapeutics2024

The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.

Allison Carles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.